Business Description
Cachet Pharmaceutical Co Ltd
NAICS : 446110
SIC : 5912
ISIN : CNE100000SN0
Share Class Description:
SZSE:002462: Class ACompare
Compare
Traded in other countries / regions
002462.China IPO Date
2010-08-18Description
Cachet Pharmaceutical Co Ltd is a state-owned stock company. Its main business includes: Medicine supply to hospitals, wholesaling of biological products, medical instruments, and traditional Chinese medicines. The Company also involved in pharmaceutical logistics and retail pharmacy chain.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.73 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 0.68 | |||||
| Debt-to-EBITDA | 5.23 | |||||
| Interest Coverage | 7.1 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.96 | |||||
| Beneish M-Score | -2.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.9 | |||||
| 3-Year EBITDA Growth Rate | -7.7 | |||||
| 3-Year EPS without NRI Growth Rate | -8.5 | |||||
| 3-Year FCF Growth Rate | 17.8 | |||||
| 3-Year Book Growth Rate | 5.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.29 | |||||
| 9-Day RSI | 50.11 | |||||
| 14-Day RSI | 53.55 | |||||
| 6-1 Month Momentum % | -1.5 | |||||
| 12-1 Month Momentum % | -16.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | |||||
| Quick Ratio | 1.32 | |||||
| Cash Ratio | 0.27 | |||||
| Days Inventory | 37.82 | |||||
| Days Sales Outstanding | 110.47 | |||||
| Days Payable | 77.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.93 | |||||
| Dividend Payout Ratio | 0.26 | |||||
| 3-Year Dividend Growth Rate | -8.1 | |||||
| Forward Dividend Yield % | 1.93 | |||||
| 5-Year Yield-on-Cost % | 4.64 | |||||
| Shareholder Yield % | 20.2 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 6.08 | |||||
| Operating Margin % | 2.86 | |||||
| Net Margin % | 0.92 | |||||
| FCF Margin % | 2.72 | |||||
| ROE % | 5.68 | |||||
| ROA % | 1.55 | |||||
| ROIC % | 6.4 | |||||
| ROC (Joel Greenblatt) % | 9.89 | |||||
| ROCE % | 8.98 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.02 | |||||
| PE Ratio without NRI | 13.49 | |||||
| Shiller PE Ratio | 11.91 | |||||
| Price-to-Owner-Earnings | 60.09 | |||||
| PS Ratio | 0.15 | |||||
| PB Ratio | 0.89 | |||||
| Price-to-Tangible-Book | 1.01 | |||||
| Price-to-Free-Cash-Flow | 5.44 | |||||
| Price-to-Operating-Cash-Flow | 4.28 | |||||
| EV-to-EBIT | 8.25 | |||||
| EV-to-EBITDA | 8.25 | |||||
| EV-to-Revenue | 0.18 | |||||
| EV-to-FCF | 6.32 | |||||
| Price-to-Projected-FCF | 0.52 | |||||
| Price-to-Median-PS-Value | 0.72 | |||||
| Price-to-Graham-Number | 0.78 | |||||
| Price-to-Net-Current-Asset-Value | 1.2 | |||||
| Earnings Yield (Greenblatt) % | 12.12 | |||||
| FCF Yield % | 18.47 | |||||
| Forward Rate of Return (Yacktman) % | 3.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cachet Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 26,698.617 | ||
| EPS (TTM) (Â¥) | 0.84 | ||
| Beta | 0.93 | ||
| Volatility % | 26.77 | ||
| 14-Day RSI | 53.55 | ||
| 14-Day ATR (Â¥) | 0.534625 | ||
| 20-Day SMA (Â¥) | 13.299 | ||
| 12-1 Month Momentum % | -16.82 | ||
| 52-Week Range (Â¥) | 9.78 - 15.3 | ||
| Shares Outstanding (Mil) | 291.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cachet Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cachet Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cachet Pharmaceutical Co Ltd Frequently Asked Questions
What is Cachet Pharmaceutical Co Ltd(SZSE:002462)'s stock price today?
The current price of SZSE:002462 is ¥13.46. The 52 week high of SZSE:002462 is ¥15.30 and 52 week low is ¥9.78.
When is next earnings date of Cachet Pharmaceutical Co Ltd(SZSE:002462)?
The next earnings date of Cachet Pharmaceutical Co Ltd(SZSE:002462) is .
Does Cachet Pharmaceutical Co Ltd(SZSE:002462) pay dividends? If so, how much?
The Dividend Yield %  of Cachet Pharmaceutical Co Ltd(SZSE:002462) is 1.93% (As of Today), Highest Dividend Payout Ratio of Cachet Pharmaceutical Co Ltd(SZSE:002462) was 0.38. The lowest was 0.11. And the median was 0.28. The  Forward Dividend Yield % of Cachet Pharmaceutical Co Ltd(SZSE:002462) is 1.93%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers